Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Dec 6, 3:30PM CST

TPST : 0.8498 (-0.82%)
Tempest Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 Quiver Quantitative, Inc. - Tue Nov 26, 1:52AM CST

Tempest Therapeutics will participate in a fireside chat at the Piper Sandler Healthcare Conference on December 3, 2024.Quiver AI SummaryTempest Therapeutics, Inc., a clinical-stage biotechnology company...

TPST : 0.8498 (-0.82%)
Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Mon Nov 25, 3:30PM CST

TPST : 0.8498 (-0.82%)
Tempest Therapeutics (TPST) Stock Jumps 83% on FDA Phase 3 Trial News wealthyventurecapitalist.com - Tue Nov 12, 6:19PM CST

Tempest Therapeutics (NASDAQ: TPST), a clinical-stage biotechnology firm focused on innovative cancer therapies, announced a significant milestone on Thursday as it secured the U.S. Food and Drug Administration’s...

TPST : 0.8498 (-0.82%)
Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Tue Nov 12, 3:21PM CST

TPST : 0.8498 (-0.82%)
Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma GlobeNewswire - Tue Nov 12, 7:00AM CST

TPST : 0.8498 (-0.82%)
Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial GlobeNewswire - Thu Oct 10, 6:01AM CDT

TPST : 0.8498 (-0.82%)
Tempest Extends Limited Duration Stockholder Rights Plan GlobeNewswire - Thu Oct 10, 6:00AM CDT

TPST : 0.8498 (-0.82%)
Tempest Therapeutics (TPST) Stock Jumps 83% on FDA Phase 3 Trial News
Tempest Therapeutics (TPST) Stock Jumps 83% on FDA Phase 3 Trial News wealthyventurecapitalist.com - Thu Aug 15, 11:44PM CDT

Tempest Therapeutics (NASDAQ: TPST), a clinical-stage biotechnology firm focused on innovative cancer therapies, announced a significant milestone on Thursday as it secured the U.S. Food and Drug Administration’s...

TPST : 0.8498 (-0.82%)
MarketBeat Week in Review – 10/16 - 10/20 MarketBeat - Sat Oct 21, 2023

All the major indexes moved lower on Friday, making it a near certainty that stocks would post their worst week in a month; the bears are firmly in control

HRL : 31.38 (-0.73%)
CPB : 41.62 (-0.05%)
LMND : 41.83 (+1.36%)
UAA : 8.37 (-0.59%)
VFS : 4.24 (+0.47%)
TSLA : 463.96 (+0.36%)
TXN : 191.16 (-0.67%)
META : 605.38 (-0.39%)
DLTR : 73.42 (+0.05%)
NFLX : 926.68 (-0.58%)
DXCM : 79.61 (-0.79%)
TPST : 0.8498 (-0.82%)

Barchart Exclusives

‘Five Day Loser’ Tyson Foods (TSN) Could Be Due for a Comeback Soon Barchart - 10 minutes ago
Although TSN stock has been the victim of unusual volatility, the fading red ink could signal a potential rebound. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot